Utah Medical Products/UTMD

$68.66

-2.13%
-
1D1W1MYTD1YMAX

About Utah Medical Products

Utah Medical Products, Inc. is engaged in the business of producing medical services. The Company markets a range of medical devices used in critical care areas, especially the neonatal intensive care unit (NICU), the labor and delivery (L&D) department and the women’s health center in hospitals, as well as medical devices sold to outpatient clinics and physician's offices. The Company’s products include BT-CATH, CVX-RIPE, CVX-RIPE, MUC-X, AROM-CO, DISPOSA-HOOD, DELTRAN PLUS, EPITOME and OptiMicro Electrosurgical Devices, Filshie Clip System, PATHFINDER PLUS, SUPRAPUBIC CATHETERIZATION, LIBERTY System, ENDOCURETTE, and LUMIN. BT-CATH is a uterine balloon tamponade catheter for controlling severe postpartum hemorrhage. MUC-X is an aspiration device used immediately after birth to clear neonatal respiratory passages and reduce exposure to potential infections. AROM-CO is a finger cover with a prong designed to rupture maternal membranes with less patient pain and anxiety.

Ticker

UTMD

Sector

Healthcare

Trading on

NASDAQ

Industry

Medical Equipment & Supplies

CEO

Kevin Cornwell

Employees

169

Headquarters

Midvale, United States

UTMD Metrics

BasicAdvanced
$251.81M
Market cap
15.34
P/E ratio
$4.57
EPS
0.13
Beta
$1.19
Dividend rate
1.71%
Dividend yield
$251.81M
0.13481
$100.59
$68.00
27.14K
$1.19
22.562
20.528
25.85%
8.816
12.83%
13.72%
13.38%
15.339
5.014
1.985
2.296
14.505
1.21%
1.7%
1.71%
-3.93%
1.13%
5.99%
14.94%
1.89%

UTMD Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
34.14% profit margin
QuarterlyAnnual
Q4 23
QoQ growth
Revenue
$12.3M
-1.6%
Net income
$4.2M
7.69%
Profit margin
34.14%
9.42%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

FAQs

What’s the current market cap for Utah Medical Products stock?

Utah Medical Products (UTMD) has a market cap of $251.81M as of April 13, 2024.

What is the P/E ratio for Utah Medical Products stock?

The price to earnings (P/E) ratio for Utah Medical Products (UTMD) stock is 15.34 as of April 13, 2024.

Does Utah Medical Products stock pay dividends?

Yes, the Utah Medical Products (UTMD) stock pays dividends to shareholders. As of April 13, 2024, the dividend rate is $1.19 and the yield is 1.71%. Utah Medical Products has a payout ratio of 25.85% on a trailing twelve-month basis.

When is the next Utah Medical Products dividend payment date?

The next Utah Medical Products (UTMD) dividend payment date is unconfirmed.

What is the beta indicator for Utah Medical Products?

Utah Medical Products (UTMD) has a beta rating of 0.13. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

What is the Utah Medical Products stock price target?

The target price for Utah Medical Products (UTMD) stock is $, which is 100% below the current price of $68.66. This is an average based on projections from analyst, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell Utah Medical Products stock

Buy or sell Utah Medical Products stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing